Loading…

5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1999-01, Vol.42 (2), p.202-205
Main Authors: BROMIDGE, S. M, BROWN, A. M, MOSS, S. F, NEWMAN, H, RILEY, G, ROUTLEDGE, C, WYMAN, P, CLARKE, S. E, DODGSON, K, GAGER, T, GRASSAM, H. L, JEFFREY, P. M, JOINER, G. F, KING, F. D, MIDDLEMISS, D. N
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 205
container_issue 2
container_start_page 202
container_title Journal of medicinal chemistry
container_volume 42
creator BROMIDGE, S. M
BROWN, A. M
MOSS, S. F
NEWMAN, H
RILEY, G
ROUTLEDGE, C
WYMAN, P
CLARKE, S. E
DODGSON, K
GAGER, T
GRASSAM, H. L
JEFFREY, P. M
JOINER, G. F
KING, F. D
MIDDLEMISS, D. N
description
doi_str_mv 10.1021/jm980532e
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_1703528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1703528</sourcerecordid><originalsourceid>FETCH-LOGICAL-p182t-3dc0a1f6e08a1dd87c2975aadf830a935a02a039e64ba6ed73661e9acdf44a8b3</originalsourceid><addsrcrecordid>eNotjM1KxDAURoMoOP4sfIMsXDjg1Zukv-5GUUcQXTiu5ba9tZG0KW0crE_kYzqDrj445_AJcaLwQqFWlx9tnmFsNO-ImYo1QpRhtCtmiFqDTrTZFwfj-IGIRmkzEz8xlI3zg4cnOIug5dD4rwkM9Lbngb5tBwomB33D3eTmG7FNNkBDwd23D431W8fjp6t9R62tWJ69XINOFUbJXF7Jhex94C6cy5Edl8Gu-VxSV0k_kHOTLKynNVlHhWMZw3KVyIFL7oMfNlmgd9_ZMRyJvZrcyMf_eyhe725XN0t4fL5_uFk8Qq8yHcBUJZKqE8aMVFVlaanzNCaq6swg5SYm1IQm5yQqKOEqNUmiOKeyqqOIssIcitO_357Gklw9UFfa8a0fbEvD9KZSNLHOzC8-JW5L</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>BROMIDGE, S. M ; BROWN, A. M ; MOSS, S. F ; NEWMAN, H ; RILEY, G ; ROUTLEDGE, C ; WYMAN, P ; CLARKE, S. E ; DODGSON, K ; GAGER, T ; GRASSAM, H. L ; JEFFREY, P. M ; JOINER, G. F ; KING, F. D ; MIDDLEMISS, D. N</creator><creatorcontrib>BROMIDGE, S. M ; BROWN, A. M ; MOSS, S. F ; NEWMAN, H ; RILEY, G ; ROUTLEDGE, C ; WYMAN, P ; CLARKE, S. E ; DODGSON, K ; GAGER, T ; GRASSAM, H. L ; JEFFREY, P. M ; JOINER, G. F ; KING, F. D ; MIDDLEMISS, D. N</creatorcontrib><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm980532e</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Biological and medical sciences ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Serotoninergic system</subject><ispartof>Journal of medicinal chemistry, 1999-01, Vol.42 (2), p.202-205</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1703528$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>BROMIDGE, S. M</creatorcontrib><creatorcontrib>BROWN, A. M</creatorcontrib><creatorcontrib>MOSS, S. F</creatorcontrib><creatorcontrib>NEWMAN, H</creatorcontrib><creatorcontrib>RILEY, G</creatorcontrib><creatorcontrib>ROUTLEDGE, C</creatorcontrib><creatorcontrib>WYMAN, P</creatorcontrib><creatorcontrib>CLARKE, S. E</creatorcontrib><creatorcontrib>DODGSON, K</creatorcontrib><creatorcontrib>GAGER, T</creatorcontrib><creatorcontrib>GRASSAM, H. L</creatorcontrib><creatorcontrib>JEFFREY, P. M</creatorcontrib><creatorcontrib>JOINER, G. F</creatorcontrib><creatorcontrib>KING, F. D</creatorcontrib><creatorcontrib>MIDDLEMISS, D. N</creatorcontrib><title>5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist</title><title>Journal of medicinal chemistry</title><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Serotoninergic system</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNotjM1KxDAURoMoOP4sfIMsXDjg1Zukv-5GUUcQXTiu5ba9tZG0KW0crE_kYzqDrj445_AJcaLwQqFWlx9tnmFsNO-ImYo1QpRhtCtmiFqDTrTZFwfj-IGIRmkzEz8xlI3zg4cnOIug5dD4rwkM9Lbngb5tBwomB33D3eTmG7FNNkBDwd23D431W8fjp6t9R62tWJ69XINOFUbJXF7Jhex94C6cy5Edl8Gu-VxSV0k_kHOTLKynNVlHhWMZw3KVyIFL7oMfNlmgd9_ZMRyJvZrcyMf_eyhe725XN0t4fL5_uFk8Qq8yHcBUJZKqE8aMVFVlaanzNCaq6swg5SYm1IQm5yQqKOEqNUmiOKeyqqOIssIcitO_357Gklw9UFfa8a0fbEvD9KZSNLHOzC8-JW5L</recordid><startdate>19990128</startdate><enddate>19990128</enddate><creator>BROMIDGE, S. M</creator><creator>BROWN, A. M</creator><creator>MOSS, S. F</creator><creator>NEWMAN, H</creator><creator>RILEY, G</creator><creator>ROUTLEDGE, C</creator><creator>WYMAN, P</creator><creator>CLARKE, S. E</creator><creator>DODGSON, K</creator><creator>GAGER, T</creator><creator>GRASSAM, H. L</creator><creator>JEFFREY, P. M</creator><creator>JOINER, G. F</creator><creator>KING, F. D</creator><creator>MIDDLEMISS, D. N</creator><general>American Chemical Society</general><scope>IQODW</scope></search><sort><creationdate>19990128</creationdate><title>5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist</title><author>BROMIDGE, S. M ; BROWN, A. M ; MOSS, S. F ; NEWMAN, H ; RILEY, G ; ROUTLEDGE, C ; WYMAN, P ; CLARKE, S. E ; DODGSON, K ; GAGER, T ; GRASSAM, H. L ; JEFFREY, P. M ; JOINER, G. F ; KING, F. D ; MIDDLEMISS, D. N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p182t-3dc0a1f6e08a1dd87c2975aadf830a935a02a039e64ba6ed73661e9acdf44a8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Serotoninergic system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BROMIDGE, S. M</creatorcontrib><creatorcontrib>BROWN, A. M</creatorcontrib><creatorcontrib>MOSS, S. F</creatorcontrib><creatorcontrib>NEWMAN, H</creatorcontrib><creatorcontrib>RILEY, G</creatorcontrib><creatorcontrib>ROUTLEDGE, C</creatorcontrib><creatorcontrib>WYMAN, P</creatorcontrib><creatorcontrib>CLARKE, S. E</creatorcontrib><creatorcontrib>DODGSON, K</creatorcontrib><creatorcontrib>GAGER, T</creatorcontrib><creatorcontrib>GRASSAM, H. L</creatorcontrib><creatorcontrib>JEFFREY, P. M</creatorcontrib><creatorcontrib>JOINER, G. F</creatorcontrib><creatorcontrib>KING, F. D</creatorcontrib><creatorcontrib>MIDDLEMISS, D. N</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BROMIDGE, S. M</au><au>BROWN, A. M</au><au>MOSS, S. F</au><au>NEWMAN, H</au><au>RILEY, G</au><au>ROUTLEDGE, C</au><au>WYMAN, P</au><au>CLARKE, S. E</au><au>DODGSON, K</au><au>GAGER, T</au><au>GRASSAM, H. L</au><au>JEFFREY, P. M</au><au>JOINER, G. F</au><au>KING, F. D</au><au>MIDDLEMISS, D. N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist</atitle><jtitle>Journal of medicinal chemistry</jtitle><date>1999-01-28</date><risdate>1999</risdate><volume>42</volume><issue>2</issue><spage>202</spage><epage>205</epage><pages>202-205</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><cop>Washington, DC</cop><pub>American Chemical Society</pub><doi>10.1021/jm980532e</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1999-01, Vol.42 (2), p.202-205
issn 0022-2623
1520-4804
language eng
recordid cdi_pascalfrancis_primary_1703528
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Biological and medical sciences
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Serotoninergic system
title 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046) : A potent, selective, and orally bioavailable 5-HT6 receptor antagonist
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T12%3A43%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide%20(SB-271046)%20:%20A%20potent,%20selective,%20and%20orally%20bioavailable%205-HT6%20receptor%20antagonist&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=BROMIDGE,%20S.%20M&rft.date=1999-01-28&rft.volume=42&rft.issue=2&rft.spage=202&rft.epage=205&rft.pages=202-205&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm980532e&rft_dat=%3Cpascalfrancis%3E1703528%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p182t-3dc0a1f6e08a1dd87c2975aadf830a935a02a039e64ba6ed73661e9acdf44a8b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true